Nycomed - Contract Services

Nycomed is a privately owned global mid-sized pharmaceutical company with a differentiated portfolio focused on branded medicines in the areas of gastroenterology, respiratory and inflammatory diseases, pain, osteoporosis and tissue management. An extensive range of OTC products completes the portfolio.

Research and development is conducted at three sites in Europe and one in India. New products are sourced from our own internal discovery organisation and in-licensed from external companies such as small biotech organisations. Establishing long-term partnerships is a cornerstone of Nycomed's growth strategy.

Nycomed has 15 manufacturing sites and two joint-ventures in 13 countries. Five centres of competence for global products are located in Europe and 11 production sites for regional products in fast-growing markets such as Brazil and Mexico. A major investment is currently being made in a new pharmaceutical plant in Russia, at present Nycomed's biggest single market.

Nycomed employs 12,000 people worldwide and has affiliates in more than 50 countries. It has a strong presence in Europe and in the emerging markets in Russia/Commonwealth of Independent States, Asia and Latin America. Headquartered in Zurich, Switzerland, the company generated total sales of EUR3.2 billion and an adjusted EBITDA of EUR1.1 billion in 2009. Nycomed ranks 28th among global pharmaceutical companies and is the 16th largest provider of medicines.

Our mission is to bring medicines that matter to patients and healthcare providers. Our vision is to become the preferred pharmaceutical company by being responsive, reliable and focusing on resultsResearch and development is conducted at three sites in Europe and one in India. New products are sourced from our own internal discovery organization and in-licensed from external companies such as small biotech organisations. Establishing long-term partnerships is a cornerstone of Nycomed's growth strategy.

Nycomed has 15 manufacturing sites and two joint-ventures in twelve countries. Five centres of competence for global products are located in Europe and 10 production sites for regional products in fast-growing markets such as Brazil and Mexico. A major investment is currently being made in a new pharmaceutical plant in Russia, at present Nycomed's biggest single market.

Nycomed employs 12,500 people worldwide and has affiliates in more than 70 countries. It has a strong presence in Europe and in the emerging markets in Russia/Commonwealth of Independent States, Latin America, Asia and the Middle East. Headquartered in Zurich, Switzerland, the company generated total sales of €3.2 billion and an adjusted EBITDA of €851 million in 2010. Nycomed ranks 28th among global pharmaceutical companies.

Our mission is to bring medicines that matter to patients and healthcare providers. Our vision is to strive for excellence in all we do to improve the quality of life for patients around the world.

Nycomed operations network

Our manufacturing operations provide a competitive advantage for the whole company through an innovative, global supply chain network. This network is constantly reviewed and optimised in the interests of increasing the utilisation of its capacity, enhancing the supply chain performance, maintaining a high level of customer service and decreasing the cost of goods sold (COGS). Thus we deliver Nycomed's products and services to its customers with the right balance of quality, reliability, responsiveness and costs.

Contract manufacturing

Ensuring the availability of Nycomed products and services for customers in the most efficient manner possible requires an integrated approach. Nycomed's operational activities are part of the company's value stream. A significant volume of contract manufacturing further optimises the utilisation of the manufacturing network.

Currently we operate 15 manufacturing facilities in 11 countries. These meet the highest international quality standards. Our combination of central and regional manufacturing ensures rapid response when opening up new and expanding existing markets.

Partnership plays a vital role in all of our operational activities. Close cross-functional collaboration and seamless processes between internal teams and external partners help us to respond quickly and accurately to market demand.

As a part of the continuous optimisation programme for our production network, we have established competence centres for certain technologies and/or pharmaceutical business areas. This helps us to increase capability in our core competence areas and to increase the capability of our core competences.

Global organisation for contract manufacturing - part of Nycomed operations strategy

Subsequent to initiating the concept of production network optimisation in 2007, Nycomed established a global organisation for contract manufacturing based on a broad range of technologies, services and incorporating the competence of a successful mid-size pharmaceutical company.

With the know-how and the capacity of our plants throughout the world, we at Nycomed are close to our customers in all important markets.

Being near to our clients is part of our understanding of providing full service. As every client and every task has specific requirements, Nycomed has to approach each situation as if it were unique. We thus tailor our services towards specific customers and task. In this way, we can provide the service that is needed.

Certificated by the most stringent and demanding authorities, Nycomed delivers its services worldwide. It also provides its expertise not only in scientific matters but also by supplementing our clients' understanding of their target markets for supply and distribution of products.

As a global company, Nycomed can provide a supply chain anywhere in the world, making sure that your products will be available when and where they are needed.

Customers from all parts of the world, from small, emerging or large pharmaceutical companies, already use these services. We are confident that you will benefit from our services too.

Lars GYLDENVANG, M. Sc. Pharmacy
Director Global Contract Manufacturing
Global Supply Chain
Nycomed Aps
PO Box 88, Langebjerg 1
4000 Roskilde
Denmark
Tel: +45 4677 1111
Fax: +45 4675 6640
lars.gyldenvang@nycomed.com

Antje FEDDERAU, Dipl.-Kffr.
Coordinator Global Contract Manufacturing
Tel: +43 732 6919 4693
Fax: +43 732 655309
antje.fedderau@nycomed.com

Nycomed Austria GmbH
St. Peter-Strasse 25
A-4020 Linz

www.nycomed.com